SAXONOV SERGE (Chief Executive Officer) sold 1.3% of their position (13.26K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $251.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/25/2025ACC: 0001610717-25-000398
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-13.26K
Net shares
Net seller
$251.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.26K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−13.26K
Price / share
$19.00
Trade value
$251.94K
% of position
1.3%
11/24/2025
1.03M→1.02M
Total
Net shares
−13.26K
Net value
-$251.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/24/2025 | S · Sale | −13.26K | $19.00 | $251.94K | 1.3% | 1.03M | 1.02M |
| Total | −13.26K | -$251.94K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned213.25K
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned58K
Total
271.28K indirect271.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 213.25K | Indirect |
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 58K | Indirect |
| Total | 271.28K | 271.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported